Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat

Neuroscience

Volumn 111, Issue 2, 2002, Pages 389-397

  Aley, K O ^a   Levine, J D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Metabolic; Pain; Peripheral neuropathy; Toxic; Traumatic

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; MU OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE C; STREPTOZOCIN; VINCRISTINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG INDUCED DISEASE; HYPERALGESIA; INJURY; MALE; NERVE LIGATION; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SECOND MESSENGER; SENSITIZATION;

ANIMALS; HYPERALGESIA; HYPERESTHESIA; MALE; NOCICEPTORS; PAIN; PAIN THRESHOLD; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SECOND MESSENGER SYSTEMS; STREPTOZOCIN; VINCRISTINE; WOUNDS AND INJURIES;

EID: 0037052826     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00009-X     Document Type: Article

References (49)

1. Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy
2. Mechanical hyperalgesia in streptozotocin-diabetic rats
3. Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat
4. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal
5. Multiple second messenger systems act sequentially to mediate rolipram-induced prolongation of prostaglandin E2-induced mechanical hyperalgesia in the rat
6. Dissociation of tolerance and dependence for opioid peripheral antinociception in rats
7. Role of protein kinase A in the maintenance of inflammatory pain
8. Rapid onset pain induced by intravenous streptozotocin in the rat
9. Nitric oxide signaling in pain and nociceptor sensitization in the rat
10. Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans
11. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain
12. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
13. Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: Evidence for G protein regulation of phospholipase A2
14. Neuropathy due to cisplatin
15. Quantitative assessment of tactile allodynia in the rat paw
16. Streptozocin-induced diabetic rats: Behavioural evidence for a model of chronic pain
17. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer
18. Behavioral changes of Wistar rats with experimentally-induced painful diabetic neuropathy
19. Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test
20. Predictive factors of resistance to treatment of neuropathic pain
21. Postherpetic neuralgia: Irritable nociceptors and deafferentation
22. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat
23. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes
24. Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats
25. Treatment of postherpetic neuralgia: An update
26. A novel nociceptor signaling pathway revealed in protein kinase C mutant mice
27. Involvement of the sympathetic postganglionic neuron in capsaicin-induced secondary hyperalgesia in the rat
28. Use of gabapentin in the treatment of neuropathic pain
29. Physiopathology of neuropathic pain syndromes
30. A transient osmotic permeabilization method for the introduction of impermeant molecules into functional brain membrane vesicles
31. Vascular dilatatory responses to sodium nitroprusside (SNP) and alpha-adrenergic antagonism in female and male normal and diabetic rats
32. The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT)
33. Peripheral neuropathy with nucleoside antiretrovirals: Risk factors, incidence and management
34. Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes
35. Adrenergic sensitivity of uninjured C-fiber nociceptors in neuropathic rats
36. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms
37. Didanosine: An updated review of its use in HIV infection
38. Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma
39. A novel behavioral model of neuropathic pain disorders produced by partial sciatic nerve injury in rats
40. Thiamine deficiency neuropathy. It's still common today
41. Peripheral mechanisms of opioid analgesia
42. The control of pain in peripheral tissue by opioids
43. Analgesic effect of intraarticular morphine after arthroscopic knee surgery
44. Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat
45. Sympathetic nerve failure in diabetes
46. Pain syndromes in AIDS
47. Transient permeabilization induced osmotically in membrane vesicles from Torpedo electroplax: A mild procedure for trapping small molecules
48. Neuropathic pain: Aetiology, symptoms, mechanisms, and management
49. HIV-associated peripheral neuropathy: Epidemiology, pathophysiology and treatment